@brandon-beaber.bsky.social
Basketball YouTube Star Tristan Jass announces he will have brain surgery for a right temporal lobe cyst discovered in 2019 after a seizure. This cyst slowly grew over 6 years and had a small enhancing component on a 2025 MRI, so surgery was recommended. youtu.be/UUPt35etmAQ?...
December 8, 2025 at 5:39 AM
Basketball YouTube Star Tristan Jass announces he will have brain surgery for a right temporal lobe cyst discovered in 2019 after a seizure. This cyst slowly grew over 6 years and had a small enhancing component on a 2025 MRI, so surgery was recommended. youtu.be/UUPt35etmAQ?...
Reposted
Longitudinal proteomic profiling of cerebrospinal fluid in untreated multiple sclerosis defines evolving disease biology
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Longitudinal proteomic profiling of cerebrospinal fluid in untreated multiple sclerosis defines evolving disease biology - Nature Communications
Longitudinal cerebrospinal fluid proteomics in multiple sclerosis uncovers dynamic antiviral immune activity, sex-based differences in damage and repair, and evolving myeloid-stromal cell interactions...
www.nature.com
December 7, 2025 at 9:56 PM
Longitudinal proteomic profiling of cerebrospinal fluid in untreated multiple sclerosis defines evolving disease biology
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Vitamin D and MS youtube.com/shorts/jW_ju...
Vitamin D and MS
YouTube video by Dr. Brandon Beaber
youtube.com
December 5, 2025 at 10:04 PM
Vitamin D and MS youtube.com/shorts/jW_ju...
subcutaneous ocrevus has been added to Australia’s Pharmaceutical Benefits Scheme and should be cheaper and more available to Australians, with a price reduction from $16,500 to as low as $31.60 www.news.com.au/lifestyle/he...
www.news.com.au
December 4, 2025 at 5:20 AM
subcutaneous ocrevus has been added to Australia’s Pharmaceutical Benefits Scheme and should be cheaper and more available to Australians, with a price reduction from $16,500 to as low as $31.60 www.news.com.au/lifestyle/he...
Alcohol & Multiple Sclerosis: Can You Drink? youtu.be/mmDyu_GT3aI?...
Alcohol & Multiple Sclerosis: Can You Drink?
YouTube video by Dr. Brandon Beaber
youtu.be
December 3, 2025 at 4:11 PM
Alcohol & Multiple Sclerosis: Can You Drink? youtu.be/mmDyu_GT3aI?...
A man in his 50s with one month of fever and numbness in the extremities. MRI showed THIS. Multiple sclerosis? No! Brain biopsy was consistent with primary large B-cell lymphoma, and he was treated with R-MPV www.jstage.jst.go.jp/article/jslr...
www.jstage.jst.go.jp
December 2, 2025 at 6:47 AM
A man in his 50s with one month of fever and numbness in the extremities. MRI showed THIS. Multiple sclerosis? No! Brain biopsy was consistent with primary large B-cell lymphoma, and he was treated with R-MPV www.jstage.jst.go.jp/article/jslr...
The NEW 2024 MS Diagnostic Criteria Explained by @aaronbostermd.bsky.social RIS, kappa light chain in CSF, central vein sign, paramagnetic rim sign, anti-MOG in children, age > 50. youtu.be/HOTDtZQLo2k?...
The NEW 2024 MS Diagnostic Criteria Explained (Game-Changer!)
YouTube video by Aaron Boster MD
youtu.be
December 1, 2025 at 4:17 PM
The NEW 2024 MS Diagnostic Criteria Explained by @aaronbostermd.bsky.social RIS, kappa light chain in CSF, central vein sign, paramagnetic rim sign, anti-MOG in children, age > 50. youtu.be/HOTDtZQLo2k?...
Multiple Sclerosis Diagnostic Criteria for Someone with a Single Attack youtube.com/shorts/Xcz2v...
Multiple Sclerosis Diagnostic Criteria for Someone with a Single Attack
YouTube video by Dr. Brandon Beaber
youtube.com
November 28, 2025 at 4:13 PM
Multiple Sclerosis Diagnostic Criteria for Someone with a Single Attack youtube.com/shorts/Xcz2v...
The FDA has approved generic vumerity produced by Zydus Lifesciences multiplesclerosisnewstoday.com/news-posts/2...
FDA approves generic version of Vumerity for relapsing MS
Zydus won final FDA approval to market a generic version of Vumerity for adults with relapsing forms of MS and active SPMS.
multiplesclerosisnewstoday.com
November 26, 2025 at 9:24 PM
The FDA has approved generic vumerity produced by Zydus Lifesciences multiplesclerosisnewstoday.com/news-posts/2...
Neurologist Explains Nate the Lawyer's Brain Tumor youtu.be/HrEKZoLkE34?...
November 26, 2025 at 4:33 PM
Neurologist Explains Nate the Lawyer's Brain Tumor youtu.be/HrEKZoLkE34?...
This is a case report of 30 year old woman taking ocrevus for multiple sclerosis who developed fever, double vision, difficulty swallowing, weakness who was found to have rhombencephalitis caused by human herpesvirus 6 (HHV-6) (very rare complication) pubmed.ncbi.nlm.nih.gov/41284955/
November 25, 2025 at 6:47 PM
This is a case report of 30 year old woman taking ocrevus for multiple sclerosis who developed fever, double vision, difficulty swallowing, weakness who was found to have rhombencephalitis caused by human herpesvirus 6 (HHV-6) (very rare complication) pubmed.ncbi.nlm.nih.gov/41284955/
Epstein-Barr virus causes MS, so everyone with MS has antibodies against EBV. OH REALLY? This study in Sri Lanka found "only" 96.3% of people with MS have antibodies (vs. 86.5% of controls) pubmed.ncbi.nlm.nih.gov/41270350/
November 24, 2025 at 10:56 PM
Epstein-Barr virus causes MS, so everyone with MS has antibodies against EBV. OH REALLY? This study in Sri Lanka found "only" 96.3% of people with MS have antibodies (vs. 86.5% of controls) pubmed.ncbi.nlm.nih.gov/41270350/
The κ-FLC index, though a useful spinal tap test to diagnose MS and is an alternative to oligoclonal bands, did not correlate at all with prognosis (top image) in the study in primary progressive multiple sclerosis pubmed.ncbi.nlm.nih.gov/41280940/
November 24, 2025 at 10:49 PM
The κ-FLC index, though a useful spinal tap test to diagnose MS and is an alternative to oligoclonal bands, did not correlate at all with prognosis (top image) in the study in primary progressive multiple sclerosis pubmed.ncbi.nlm.nih.gov/41280940/
The average cost of a brain MRI in Africa is only about $150 US Dollars pubmed.ncbi.nlm.nih.gov/41280946/
The Current State of Diagnostics for Neuroimmunological Disorders in Africa - PubMed
The epidemiology of neuroimmunological disorders in Africa remains poorly understood. Regional variation in diagnostics and provider knowledge has led to challenges in real-world application of diagnostic criteria. We conducted a cross-sectional survey of clinicians practicing in Africa to character …
pubmed.ncbi.nlm.nih.gov
November 24, 2025 at 10:46 PM
The average cost of a brain MRI in Africa is only about $150 US Dollars pubmed.ncbi.nlm.nih.gov/41280946/
multiple sclerosis is associated with antibodies against ceramide-1-phosphate (C1P) (p = 0.0005) compared to people with other neurological diseases (n = 39 with MS) pubmed.ncbi.nlm.nih.gov/41282114/
Presence and relevance of serum anti-C1P IgG antibodies in relapsing-remitting multiple sclerosis - PubMed
There is a growing interest in the role of sphingolipids in the background of multiple sclerosis (MS). The goal of this study was to evaluate the serum levels of antibodies against ceramide-1-phosphate (C1P) subclasses and their relationships with clinical status in MS.The study groups comprised 39 …
pubmed.ncbi.nlm.nih.gov
November 24, 2025 at 10:43 PM
multiple sclerosis is associated with antibodies against ceramide-1-phosphate (C1P) (p = 0.0005) compared to people with other neurological diseases (n = 39 with MS) pubmed.ncbi.nlm.nih.gov/41282114/
The United Arab Emirates (UAE) approve Tolebrutinib (CENRIFKI®), and inhibitor of Bruton's tyrosine kinase (BTK) for non-relapsing secondary progressive multiple sclerosis (nrSPMS) pubmed.ncbi.nlm.nih.gov/41284222/
Tolebrutinib: First Approval - PubMed
Tolebrutinib (CENRIFKI<sup>®</sup>) is an orally available, brain-penetrant small molecule inhibitor of Bruton's tyrosine kinase (BTK) being developed by Sanofi for the treatment of multiple sclerosis (MS). On 26 August 2025, tolebrutinib received its first approval in the United Arab Emirates (UAE) …
pubmed.ncbi.nlm.nih.gov
November 24, 2025 at 10:39 PM
The United Arab Emirates (UAE) approve Tolebrutinib (CENRIFKI®), and inhibitor of Bruton's tyrosine kinase (BTK) for non-relapsing secondary progressive multiple sclerosis (nrSPMS) pubmed.ncbi.nlm.nih.gov/41284222/
12 year old girl diagnosed with tonsilitis at age 3 and later anti-GAD limbic encephalitis, thyroiditis, type 1 diabetes, celiac disease. Father with "multiple sclerosis." Skin biopsy (Protein Gene Product 9.5 marker, magnification 10X (a) and 20X (b)) showed this! Diagnosis?
November 20, 2025 at 10:54 PM
12 year old girl diagnosed with tonsilitis at age 3 and later anti-GAD limbic encephalitis, thyroiditis, type 1 diabetes, celiac disease. Father with "multiple sclerosis." Skin biopsy (Protein Gene Product 9.5 marker, magnification 10X (a) and 20X (b)) showed this! Diagnosis?
spinal Leptomeningeal enhancement can be a feature of Myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), especially in children. www.neurology.org/doi/10.1212/...
November 20, 2025 at 10:46 PM
spinal Leptomeningeal enhancement can be a feature of Myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), especially in children. www.neurology.org/doi/10.1212/...
subcutaneous tysabri is coming for people with MS. this small observational study (n = 63) with 300mg found very low rates of relapses (0.03 per person per year), new MRI lesions. pubmed.ncbi.nlm.nih.gov/41260150/
November 20, 2025 at 9:34 PM
subcutaneous tysabri is coming for people with MS. this small observational study (n = 63) with 300mg found very low rates of relapses (0.03 per person per year), new MRI lesions. pubmed.ncbi.nlm.nih.gov/41260150/
An mRNA vaccine against Epstein-Barr virus (EBV) will be tested in an early-stage Phase 2 trial in 180 people recently diagnosis with MS. www.independent.co.uk/news/health/...
Common virus jab could be key in fight against multiple sclerosis
The vaccine will be trialled in patients recently diagnosed with MS
www.independent.co.uk
November 20, 2025 at 9:25 PM
An mRNA vaccine against Epstein-Barr virus (EBV) will be tested in an early-stage Phase 2 trial in 180 people recently diagnosis with MS. www.independent.co.uk/news/health/...
Clay Walker's Multiple Sclerosis Battle youtu.be/bvgdvonXvWU?...
Clay Walker's Multiple Sclerosis Battle
YouTube video by Dr. Brandon Beaber
youtu.be
November 19, 2025 at 9:03 PM
Clay Walker's Multiple Sclerosis Battle youtu.be/bvgdvonXvWU?...
Are these MRI findings in people with multiple sclerosis? Shockingly, NO! They actually have Wolfram syndrome (WFS), a rare genetic disorder associated with pathogenic variants in WFS1 and is linked to optic atrophy, hearing loss and diabetes. www.frontiersin.org/journals/neu...
November 18, 2025 at 3:59 AM
Are these MRI findings in people with multiple sclerosis? Shockingly, NO! They actually have Wolfram syndrome (WFS), a rare genetic disorder associated with pathogenic variants in WFS1 and is linked to optic atrophy, hearing loss and diabetes. www.frontiersin.org/journals/neu...
Lifestyle predictors of multiple sclerosis in Kuwait. Obesity is associated with triple the risk (adjusted OR = 3.12, 95% CI: 1.34-7.25) and high salt intake is linked to quintiple the risk (adjusted OR = 5.05, 95% CI: 2.22-11.51) pubmed.ncbi.nlm.nih.gov/41248103/
The role of dietary and lifestyle factors in multiple sclerosis risk in a middle eastern country: A case-control study - PubMed
This study identified high sodium intake, inadequate vitamin B2 consumption, and obesity as significant risk factors for MS, while regular light physical activity appeared to lower MS risk. Public health initiatives addressing these factors may help reduce MS risk in Kuwait and other similar setting …
pubmed.ncbi.nlm.nih.gov
November 18, 2025 at 3:51 AM
Lifestyle predictors of multiple sclerosis in Kuwait. Obesity is associated with triple the risk (adjusted OR = 3.12, 95% CI: 1.34-7.25) and high salt intake is linked to quintiple the risk (adjusted OR = 5.05, 95% CI: 2.22-11.51) pubmed.ncbi.nlm.nih.gov/41248103/
Tyruko, a tysabri biosimilar for multiple sclerosis, is now available in the US. www.fiercepharma.com/pharma/after...
After delay, Sandoz's biosimilar Tyruko launches in US to pressure Biogen's blockbuster MS med Tysabri
The clock is up on Biogen’s extra two years of a biosimilar-free U.S. market for its blockbuster multiple sclerosis (MS) med Tysabri. | Biogen has had two years to gear up for the impending launch of ...
www.fiercepharma.com
November 18, 2025 at 3:48 AM
Tyruko, a tysabri biosimilar for multiple sclerosis, is now available in the US. www.fiercepharma.com/pharma/after...